Human Creatine Kinase MB Isoenzyme (CKMB) ELISA kit
Product Images
Specifications
Product Data | |
Format | 8x12 divisible strips |
Assay Type | Solid Phase Sandwich ELISA |
Assay Length | 3 hours |
Signal | Colorimetric |
Sample Type | Serum |
Specificity | This kit is used for quantitative detection human Creatine Kinase MB Isoenzyme (CKMB) |
Reactivities | Human |
Cross Reactivity | There is no detectable cross-reactivity with other relevant proteins. |
Interference | No significant interference observed with available related molecules. |
Components |
|
Background | Creatine Kinase (CK-MB) is the enzyme being used as the definitive serum marker for the diagnosis or exclusion of acute myocardial infarction (AMI).The determination of CK-MB mass has proven to be more specific for myocardial necrosis than the long-standing CK-MB activity and CK-MB inhibition assays. CK- MB, released after AMI, is detectable in blood as early as 3-4 hours after the onset of symptoms, and remains elevated for approximately 65 hours post infarct 8-9. CK-MB mass levels are reportedly 50% diagnostic for AMI after 3 hours and > 90% diagnostic at 6 hours 10. Such accuracy makes CK-MB mass determinations useful in confirming AMI in patients presenting to the ER with non-diagnostic ECGs > 6 hours after the onset of symptoms. |
Gene Symbol | CKM |
Gene ID | 1158 |
Documents
SDS |